Adagio TherapeuticsListed
adagiotx.combiotech_life_sciences
Adagio Therapeutics is focused on developing antibody drugs for the treatment and prevention of Covid-19.
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Adagio Therapeutics is focused on developing antibody drugs for the treatment and prevention of Covid-19.
Aerium is dedicated to the discovery & development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic & pandemic threats.
Alpine Immune Sciences is a clinical stage biopharmaceutical company dedicated to discovering and developing innovative, protein-based immunotherapies targeting the immune synapse…
Alumis is advancing a late-stage portfolio of next-generation targeted therapies for immune-mediated diseases, designed to optimize impact and transform patient care - helping mil…
Anjarium Biosciences is a cell and gene therapy tools and technology company headquartered in Switzerland. Our mission is to enable researchers and manufacturers to accelerate the…
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, addressing significant unmet needs in the…
Arrakis Therapeutics is pioneering a new class of genetic medicines known as RNA-targeted small molecules (rSMs), aiming to unlock new biology for patients by creating oral medici…
Artios Pharma is focused on developing innovative therapies for cancer treatment through its proprietary DNA Damage Response (DDR) platform.
A clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing oral antiviral therapies to address unmet medical needs for patients with seriou…
Aviceda Therapeutics is a clinical-stage biotech company focused on developing novel therapies for immune-mediated diseases, particularly targeting macular degeneration, a leading…
Beam Therapeutics is a biotechnology company focused on developing precision genetic medicines using base editing technology to treat serious diseases.
Beta Bionics is focused on developing innovative solutions for diabetes management, including the iLet Bionic Pancreas, which automates insulin delivery for individuals with diabe…
Bicara Therapeutics is focused on developing innovative targeted therapies for cancer treatment, specifically through the use of dual-action antibodies that modulate the tumor mic…
BioInvent is a clinical-stage company that discovers and develops antibodies for cancer therapy, focusing on innovative immuno-oncology drug candidates.
Callio Therapeutics is developing next-generation, dual-payload antibody-drug conjugates (ADCs) that enable targeted delivery of drug combinations to tumor cells, aiming to maximi…
CatalYm is pioneering the neutralization of GDF-15 to overcome cancer therapy resistance, developing safe and efficacious immune therapies for solid tumors, particularly focusing…
CDR-Life is focused on transforming the treatment of cancer and autoimmune diseases through its innovative T cell engager (TCE) platform, M-gager®. The company develops highly sel…
Chord Therapeutics is a pharmaceutical corporation in the clinical stage of drug development. They specialize in creating medications for patients with rare and severe illnesses t…
Cidara Therapeutics is a research-intensive biopharmaceutical company focused on developing important medicines and vaccines, particularly in areas such as oncology, infectious di…
We are a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high u…
DBV Technologies is a global clinical stage biopharmaceutical company focused on advancing epicutaneous immunotherapy using its innovative VIASKIN® patch technology to treat food…
Editas Medicine is a pioneering gene editing company focused on developing transformative medicines using CRISPR technology to treat serious diseases.
Enanta Pharmaceuticals is dedicated to creating novel medicines through rigorous research and innovative chemistry, focusing on high unmet medical needs in areas such as hepatitis…
Endeavor BioMedicines is a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threate…
enGene is focused on developing non-viral genetic medicines, particularly for treating non-muscle invasive bladder cancer (NMIBC) through its investigational therapy, Detalimogene.
ESSA is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. ESSA’s lead clinical candidate, EPI-7386, represents a…
EyeBio is a subsidiary of Merck focused on developing therapies aimed at protecting, restoring, and improving vision for people living with eye diseases, particularly retinal dise…
First Wave BioPharma, Inc. is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.
FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics targeting DNA Replication Stress in treatment-resistant cancers.
Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development of its investigational drug product, seralutinib, for the treatment of pulmonary arterial hyp…
Icosavax is a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial fo…
Immunocore is a commercial-stage biotechnology company that discovered, developed and commercialized the world’s first approved T cell receptor (TCR) therapy. The company aims to…
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to atta…
Juno Therapeutics is now part of Bristol Myers Squibb, a global biopharmaceutical company focused on cancer care. The company develops new medicines through innovative research.
Kestra Medical Technologies is a wearable medical device and digital healthcare company that protects patients with diagnostic and therapeutic technologies that are intuitive, int…
Kezar Life Sciences is a clinical-stage biotechnology company that develops novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, including products…
Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases. The comp…
Lexeo Therapeutics is a clinical stage genetic medicine company dedicated to reshaping heart health by applying pioneering science to fundamentally change how cardiovascular disea…
Marea Therapeutics is focused on developing next-generation medicines for cardioendocrine diseases by leveraging large-scale human genetic data and advancements in biology.
Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, advancing preclinical programs in autoimmunity, fibrosis, vascular disorders, and immuno…
Resilience is a biomanufacturing CDMO specializing in biologics and cell and gene therapy. They provide end-to-end development, scale-up, and tech transfer services to accelerate…
nChroma Bio is a genetic medicines company committed to addressing the limitations of existing therapies through a disease-first approach. By combining programmable in vivo delive…
NRG Therapeutics is an innovative, clinical stage neuroscience drug discovery company focused on developing transformative treatments for neurodegenerative diseases such as ALS an…
Nuvation Bio is a global oncology company focused on tackling some of the toughest challenges in cancer treatment. The company aims to develop and commercialize new generations of…
Ousia Pharma is a Danish biotech start-up focused on the development of novel peptide-drug conjugates for the treatment of metabolic diseases, utilizing a targeting approach to de…
Prevail Therapeutics is a biotechnology company developing gene therapies aimed at addressing the genetic root causes of neurodegenerative diseases, including Parkinson's disease…
Replimune is a biotech company focused on revolutionizing cancer treatment with a new class of oncolytic immunotherapies intended to activate a powerful and durable full-body anti…
Sail Biomedicines is a biotech company focused on developing programmable medicines using RNA and nanoparticles, aiming to transform patient care through innovative treatments.
Sana Biotechnology is focused on engineered cells as medicines, aiming to repair and control genes or replace missing or damaged cells to address the underlying causes of diseases.
Scorpion is a clinical-stage, precision oncology company developing transformational targeted therapies for patients with cancer. We have built proprietary and fully-integrated di…
Senti Bio is a clinical-stage company developing a new generation of cell and gene therapies for patients living with incurable diseases. Leveraging a synthetic biology platform,…
Spiro Medical is developing an implantable neuromodulation system designed to address the unmet needs of patients with severe, uncontrolled asthma.
Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet need.
Synthekine is a biotechnology company focused on discovering, developing, and commercializing selective cytokine therapeutics to treat cancer and autoimmune diseases.
Syros is redefining the power of small molecules to control the expression of genes. Based on its unique ability to elucidate regulatory regions of the genome, Syros aims to devel…
Details are not available yet. The company remains listed.
Third Arc Bio is innovating antibody therapeutics by developing multifunctional antibodies that engage multiple targets and cell types, focusing on oncology and immunology.
Details are not available yet. The company remains listed.
Trevi Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing Haduvio (oral nalbuphine ER) to help patients suffering from chronic cough conditions, inc…
Upstream Bio is a clinical-stage biotechnology company focused on developing verekitug, a monoclonal antibody targeting the TSLP receptor to treat severe respiratory diseases driv…
Vaderis Therapeutics is a Swiss biopharmaceutical company focused on rare vascular diseases, developing VAD044 for Hereditary Hemorrhagic Telangiectasia (HHT).
Vanqua Bio is a biopharmaceutical company focused on discovering and developing next-generation medicines for neurodegenerative diseases, particularly targeting glucocerebrosidase…
Visterra is a biologics research company developing therapies for patients with immune-mediated and other hard-to-treat diseases.
XII Medical is a company developing therapies for sleep apnea. It also offers a self-hosted Git service.
Alveus Therapeutics is focused on developing next-generation metabolic therapies aimed at sustainable weight loss and improved patient outcomes in the obesity treatment landscape.
Caldera Therapeutics is a Boston-based biotechnology company dedicated to developing innovative therapeutic solutions for inflammatory bowel disease and other immunologic conditio…
Protego Biopharma is a clinical-stage biotechnology company dedicated to pioneering first-in-class small molecule therapeutics that reprogram protein folding to address systemic a…
Windward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committed to transforming the treatment of people living w…